Yimitasvir Phosphate
PCD-DDAG181PA-18-004
Phase 1 small_molecule completed
Quick answer
Yimitasvir Phosphate for Hepatic Impairment is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Hepatic Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed